M
Company · Healthtech & Bio
Medlumics
Medlumics is a Madrid-based (Tres Cantos) medical device company founded in 2009 that developed AblaView, a cardiac ablation catheter system guided in real time by optical coherence tomography (OCT) tissue sensing, for treating atrial fibrillation; it later moved to a pulsed-field ablation version and published first-in-human results in 2025. It raised roughly $70M across rounds up to a €14M Series E co-led by Asabys Partners, VI Partners and CDTI Innvierte. Medlumics SL is in liquidation.
Founded
2009
Founders
2
News
0
Rounds
4
Investors
12
SectorsMedical Devices, Healthtech, Cardiology, Photonics, Deeptech
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Profile updated 9 Aug 2026
Founders
E
Eduardo Margallo Balbás
Co-founder and former CEO/COO
J
José Luis Rubio Guivernau
Co-founder and former CTO
Global models
No comparables on record yet.
Investors 12
AAndera Partners
AAsabys Partners
asabys.com
CCaixa Capital Risc (Criteria Bioventures)
CCDTI Innvierte
www.cdti.es
CCriteria Venture Tech
criteriaventuretech.com
EEdmond de Rothschild Investment Partners
Innogest Capital
KKurma Partners
MMedTech Innovator
SSeroba Life Sciences
VVI Partners
YYsios Capital
ysioscapital.com
Funding rounds 4
News & media
No coverage on record yet.